272 related articles for article (PubMed ID: 26518224)
1. Vitamin D in clinically isolated syndrome: evidence for possible neuroprotection.
Mowry EM; Pelletier D; Gao Z; Howell MD; Zamvil SS; Waubant E
Eur J Neurol; 2016 Feb; 23(2):327-32. PubMed ID: 26518224
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D as an early predictor of multiple sclerosis activity and progression.
Ascherio A; Munger KL; White R; Köchert K; Simon KC; Polman CH; Freedman MS; Hartung HP; Miller DH; Montalbán X; Edan G; Barkhof F; Pleimes D; Radü EW; Sandbrink R; Kappos L; Pohl C
JAMA Neurol; 2014 Mar; 71(3):306-14. PubMed ID: 24445558
[TBL] [Abstract][Full Text] [Related]
3. Does vitamin D deficiency predict early conversion of clinically isolated syndrome? A preliminary Egyptian study.
Shaheen HA; Sayed SS; Daker LI; AbdelAziz HE; Taha MA
Int J Neurosci; 2018 Oct; 128(10):946-951. PubMed ID: 29493311
[TBL] [Abstract][Full Text] [Related]
4. Body mass index, but not vitamin D status, is associated with brain volume change in MS.
Mowry EM; Azevedo CJ; McCulloch CE; Okuda DT; Lincoln RR; Waubant E; Hauser SL; Pelletier D
Neurology; 2018 Dec; 91(24):e2256-e2264. PubMed ID: 30429274
[TBL] [Abstract][Full Text] [Related]
5. Association of Vitamin D Levels With Multiple Sclerosis Activity and Progression in Patients Receiving Interferon Beta-1b.
Fitzgerald KC; Munger KL; Köchert K; Arnason BG; Comi G; Cook S; Goodin DS; Filippi M; Hartung HP; Jeffery DR; O'Connor P; Suarez G; Sandbrink R; Kappos L; Pohl C; Ascherio A
JAMA Neurol; 2015 Dec; 72(12):1458-65. PubMed ID: 26458124
[TBL] [Abstract][Full Text] [Related]
6. Vitamin D levels and risk of multiple sclerosis in patients with clinically isolated syndromes.
Martinelli V; Dalla Costa G; Colombo B; Dalla Libera D; Rubinacci A; Filippi M; Furlan R; Comi G
Mult Scler; 2014 Feb; 20(2):147-55. PubMed ID: 23836877
[TBL] [Abstract][Full Text] [Related]
7. MRI correlates of disability progression in patients with CIS over 48 months.
Uher T; Horakova D; Bergsland N; Tyblova M; Ramasamy DP; Seidl Z; Vaneckova M; Krasensky J; Havrdova E; Zivadinov R
Neuroimage Clin; 2014; 6():312-9. PubMed ID: 25379444
[TBL] [Abstract][Full Text] [Related]
8. Cerebrospinal fluid neurofilament light levels mark grey matter volume in clinically isolated syndrome suggestive of multiple sclerosis.
Tortorella C; Direnzo V; Ruggieri M; Zoccolella S; Mastrapasqua M; D'Onghia M; Paolicelli D; Cuonzo FD; Gasperini C; Trojano M
Mult Scler; 2018 Jul; 24(8):1039-1045. PubMed ID: 28537100
[TBL] [Abstract][Full Text] [Related]
9. Vitamin D metabolites are associated with clinical and MRI outcomes in multiple sclerosis patients.
Weinstock-Guttman B; Zivadinov R; Qu J; Cookfair D; Duan X; Bang E; Bergsland N; Hussein S; Cherneva M; Willis L; Heininen-Brown M; Ramanathan M
J Neurol Neurosurg Psychiatry; 2011 Feb; 82(2):189-95. PubMed ID: 21047880
[TBL] [Abstract][Full Text] [Related]
10. A randomised, double blind, placebo controlled trial with vitamin D3 as an add on treatment to interferon β-1b in patients with multiple sclerosis.
Soilu-Hänninen M; Aivo J; Lindström BM; Elovaara I; Sumelahti ML; Färkkilä M; Tienari P; Atula S; Sarasoja T; Herrala L; Keskinarkaus I; Kruger J; Kallio T; Rocca MA; Filippi M
J Neurol Neurosurg Psychiatry; 2012 May; 83(5):565-71. PubMed ID: 22362918
[TBL] [Abstract][Full Text] [Related]
11. A longitudinal study of serum 25-hydroxyvitamin D and intact parathyroid hormone levels indicate the importance of vitamin D and calcium homeostasis regulation in multiple sclerosis.
Soilu-Hänninen M; Laaksonen M; Laitinen I; Erälinna JP; Lilius EM; Mononen I
J Neurol Neurosurg Psychiatry; 2008 Feb; 79(2):152-7. PubMed ID: 17578859
[TBL] [Abstract][Full Text] [Related]
12. Clinically Isolated Syndrome Suggestive of Multiple Sclerosis: Dynamic Patterns of Gray and White Matter Changes-A 2-year MR Imaging Study.
Rocca MA; Preziosa P; Mesaros S; Pagani E; Dackovic J; Stosic-Opincal T; Drulovic J; Filippi M
Radiology; 2016 Mar; 278(3):841-53. PubMed ID: 26348234
[TBL] [Abstract][Full Text] [Related]
13. Vitamin D and disease activity in multiple sclerosis before and during interferon-β treatment.
Løken-Amsrud KI; Holmøy T; Bakke SJ; Beiske AG; Bjerve KS; Bjørnarå BT; Hovdal H; Lilleås F; Midgard R; Pedersen T; Benth JS; Sandvik L; Torkildsen O; Wergeland S; Myhr KM
Neurology; 2012 Jul; 79(3):267-73. PubMed ID: 22700809
[TBL] [Abstract][Full Text] [Related]
14. Low 25-hydroxyvitamin D, but not the bioavailable fraction of 25-hydroxyvitamin D, is a risk factor for multiple sclerosis.
Behrens JR; Rasche L; Gieß RM; Pfuhl C; Wakonig K; Freitag E; Deuschle K; Bellmann-Strobl J; Paul F; Ruprecht K; Dörr J
Eur J Neurol; 2016 Jan; 23(1):62-7. PubMed ID: 26220765
[TBL] [Abstract][Full Text] [Related]
15. Higher Serum 25-Hydroxyvitamin D and Lower Plasma Glucose Are Associated with Larger Gray Matter Volume but Not with White Matter or Total Brain Volume in Dutch Community-Dwelling Older Adults.
Brouwer-Brolsma EM; van der Zwaluw NL; van Wijngaarden JP; Dhonukshe-Rutten RA; in 't Veld PH; Feskens EJ; Smeets PA; Kessels RP; van de Rest O; de Groot LC
J Nutr; 2015 Aug; 145(8):1817-23. PubMed ID: 26136594
[TBL] [Abstract][Full Text] [Related]
16. Association of Deep Gray Matter Damage With Cortical and Spinal Cord Degeneration in Primary Progressive Multiple Sclerosis.
Ruggieri S; Petracca M; Miller A; Krieger S; Ghassemi R; Bencosme Y; Riley C; Howard J; Lublin F; Inglese M
JAMA Neurol; 2015 Dec; 72(12):1466-74. PubMed ID: 26457955
[TBL] [Abstract][Full Text] [Related]
17. Increased cortical curvature reflects white matter atrophy in individual patients with early multiple sclerosis.
Deppe M; Marinell J; Krämer J; Duning T; Ruck T; Simon OJ; Zipp F; Wiendl H; Meuth SG
Neuroimage Clin; 2014; 6():475-87. PubMed ID: 25610761
[TBL] [Abstract][Full Text] [Related]
18. Dynamics of brain iron levels in multiple sclerosis: A longitudinal 3T MRI study.
Khalil M; Langkammer C; Pichler A; Pinter D; Gattringer T; Bachmaier G; Ropele S; Fuchs S; Enzinger C; Fazekas F
Neurology; 2015 Jun; 84(24):2396-402. PubMed ID: 25979698
[TBL] [Abstract][Full Text] [Related]
19. Sun exposure and vitamin D are independent risk factors for CNS demyelination.
Lucas RM; Ponsonby AL; Dear K; Valery PC; Pender MP; Taylor BV; Kilpatrick TJ; Dwyer T; Coulthard A; Chapman C; van der Mei I; Williams D; McMichael AJ
Neurology; 2011 Feb; 76(6):540-8. PubMed ID: 21300969
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D Supplementation Trials Aimed at Reducing Mortality Have Much Higher Power When Focusing on People with Low Serum 25-Hydroxyvitamin D Concentrations.
Brenner H; Jansen L; Saum KU; Holleczek B; Schöttker B
J Nutr; 2017 Jul; 147(7):1325-1333. PubMed ID: 28539415
[No Abstract] [Full Text] [Related]
[Next] [New Search]
